Lexeo Therapeutics, Inc. Common StockLXEONASDAQ
LOADING
|||
Switch Symbol:
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-105.77M
↓ 82% below average
Average (4y)
$-58.00M
Historical baseline
Range
High:$-4.59M
Low:$-105.77M
CAGR
+119.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-105.77M | -54.4% |
| 2023 | $-68.51M | -13.2% |
| 2022 | $-60.51M | -19.5% |
| 2021 | $-50.64M | -1003.7% |
| 2020 | $-4.59M | - |